PHARMAMENTOR AS
Operating
Mentorvirksomhet og strategisk rådgivning
innen legemiddelindustri, ledelse og kommunikasjon og annet som
naturlig faller sammen med dette, herunder å delta i andre selskaper
og lignende virksomheter, kjøp og salg av aksjer eller på andre måter
gjøre seg interessert i andre foretagender.
Organization
- CEO
- ÅN
Åge Nærdal1956
- Chairman of the board
- ÅN
Åge Nærdal1956
- Years since formation
- 11 years
- since Sep 30, 2015
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 300
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Annual total result 2025
- 50,159
- NOK
- Total equity 2025
- 44,940
- NOK
Last update: Jun 3, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
ÅN 1956 | Managing Director/CEO | 100 % directly |
Board
| Name | Role | Shares |
|---|---|---|
ÅN 1956 | Chairman | 100 % directly |
TL | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
ÅN 1956 | Managing Director/CEO, Chairman | 100 % directly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
ÅN 1956 | Ordinary shares | 300 | 100 % |
Shares owned by the PHARMAMENTOR AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| NO0012753625 | 6,085,050 | 8.51 % | |
| Ordinary shares | 17,423 | 1.12 % | |
| NO0010859580 | 89,744 | 0.35 % | |
I Under liquidation | Ordinary shares | 4,333 | 0.11 % |
P Under liquidation | NO0010405640 | 13,300 | 0.04 % |
| NO0010714785 | 769 | < 0.01 % | |
| NO0010895568 | 2,500 | < 0.01 % | |
| NO0013033795 | 366 | < 0.01 % | |
| NO0010852213 | 1,100 | < 0.01 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 | 769,245 |
Annual Total Result | 50,159 | -452,106 | -358,122 | 31,824 | -633,968 |
Total assets | 538,067 | 197,097 | 523,375 | 851,594 | 967,896 |
Total liabilities | 493,126 | 202,316 | 76,488 | 46,585 | 194,711 |
Total equity | 44,940 | -5,219 | 446,887 | 805,009 | 773,185 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 | 769,245 |
Total operating costs | 73,154 | 71,956 | 110,539 | 123,125 | 847,311 |
Operating result | -73,154 | -71,956 | -110,539 | -123,125 | -78,067 |
Financial income/costs | 123,313 | -380,150 | -247,583 | 154,949 | -557,882 |
Profit before tax | 50,159 | -452,106 | -358,122 | 31,824 | -635,948 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 | -1,980 |
Annual Total Result | 50,159 | -452,106 | -358,122 | 31,824 | -633,968 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 0 | 0 | 0 | 0 | 3,000 |
Total current assets | 538,067 | 197,097 | 523,375 | 851,594 | 964,896 |
Total assets | 538,067 | 197,097 | 523,375 | 851,594 | 967,896 |
Short term debt | 493,126 | 202,316 | 76,488 | 863 | 80,421 |
Long term debt | 0 | 0 | 0 | 45,722 | 114,290 |
Total liabilities | 493,126 | 202,316 | 76,488 | 46,585 | 194,711 |
Contributed capital | 25,000 | 25,000 | 25,000 | 25,000 | 25,000 |
Retained earnings | 19,940 | -30,219 | 421,887 | 780,009 | 748,185 |
Total equity | 44,940 | -5,219 | 446,887 | 805,009 | 773,185 |
Total equity and liabilities | 538,067 | 197,097 | 523,375 | 851,594 | 967,896 |
Classification
21st company classification
BETA
Scaleup
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises